Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07268690 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. This study will evaluate whether omitting Level Va irradiation in patients without these risk features does not compromise regional control or survival, with the goal of providing robust evidence to guide further personalization of NPC radiotherapy.
Trial Details
NCT Number NCT07268690
Lead Sponsor Fujian Cancer Hospital
Conditions
(from sponsor)		 Nasopharyngeal Carcinoma by AJCC V9 Stage
Enrollment 474 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov